- Trials with a EudraCT protocol (26)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
26 result(s) found for: Cannabis.
Displaying page 1 of 2.
EudraCT Number: 2008-000766-23 | Sponsor Protocol Number: D1443C00018 | Start Date*: 2008-12-22 |
Sponsor Name:Medical School Hannover, Department of Psychiatry, Socialpsychiatry and Psychotherapy | ||
Full Title: Effects of QuetiapineXR in schizophrenic patients with cannabis abuse and/or cannabis induced psychosis -pilot study- | ||
Medical condition: cannabis induced psychosis/schizophrenic patients with cannabis abuse | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005263-29 | Sponsor Protocol Number: 25-01 | Start Date*: 2006-01-31 |
Sponsor Name:Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research) [...] | ||
Full Title: Multiple Sclerosis and Extract of Cannabis (MUSEC): A randomised, double-blind, placebo-controlled phase III trial to determine the efficacy and safety of a standardised oral extract of Cannabis sa... | ||
Medical condition: Multiple Sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002315-98 | Sponsor Protocol Number: MedicalcannabisMSSCI2018 | Start Date*: 2018-12-06 | ||||||||||||||||
Sponsor Name:Aarhus Universitetshospital | ||||||||||||||||||
Full Title: The effect of medical cannabis on neuropathic pain and spasticity in patients with Multiple Sclerosis and in patients with spinal cord injury. A multicenter national placebo-controlled trial | ||||||||||||||||||
Medical condition: Central neuropathic pain and spasticity | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-005198-38 | Sponsor Protocol Number: CANNA1 | Start Date*: 2018-10-26 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Tetra-hydro-cannabinol, cannabidiol and their combination for the treatment of peripheral neuropathic pain. A randomised placebo-controlled trial. | |||||||||||||
Medical condition: Peripheral neuropathic pain due to polyneuropathy, postherpetic neuralgia, or peripheral nerve injury (surgical or traumatic). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000393-47 | Sponsor Protocol Number: SP000680 | Start Date*: 2004-09-22 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: Effect of Cannabis Based Medicine Extract Sativex on brain function as assessed by fMRI and neurophysiologic evaluation in patients with Multiple Sclerosis a double blind, randomised, placebo-co... | |||||||||||||
Medical condition: Treatment of spasticity in patients with Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003574-13 | Sponsor Protocol Number: 020683 | Start Date*: 2018-03-08 | ||||||||||||||||
Sponsor Name:Aalborg university hospital dept. of rheumatology | ||||||||||||||||||
Full Title: The NordCAN study: Cannabis treatment in hand osteoarthritis and psoriatic arthritis. A randomized, double-blind placebo controlled study | ||||||||||||||||||
Medical condition: Psoriatic Arthritis Hand Osteoarthritis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-002728-33 | Sponsor Protocol Number: CUPID2005 | Start Date*: 2006-02-28 |
Sponsor Name:Plymouth Hospitals NHS Trust | ||
Full Title: Cannabinoid Use in Progressive Inflammatory brain Disease | ||
Medical condition: Progressive multiple sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005344-17 | Sponsor Protocol Number: CBDV_2014 | Start Date*: 2015-08-21 |
Sponsor Name:Department of Anesthesiology and Operative Intensive Care Medicine, Charité (CBF) | ||
Full Title: Oral cannabidivarin (CBDV) solution for treatment of HIV-associated neuropathic pain – a randomized, double-blind, placebo-controlled phase II study. | ||
Medical condition: Chronic painful HIV-associated neuropathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-006236-63 | Sponsor Protocol Number: EVT 302/3011 | Start Date*: 2008-01-23 | |||||||||||
Sponsor Name:Evotec Neurosciences GmbH | |||||||||||||
Full Title: A double-blind, randomized, placebo- and NRT-controlled Phase II study to assess the effects of EVT 302 alone and in combination with NRT on craving and withdrawal in healthy male smokers deprived ... | |||||||||||||
Medical condition: Smoking cessation. Assessment of the effect of EVT 302 alone or in combination with a nicotine replacement therapy (NRT) on craving and withdrawal in smokers after short-term deprivation of cigare... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016065-29 | Sponsor Protocol Number: GWCA0962 | Start Date*: 2010-03-10 | |||||||||||
Sponsor Name:GW Pharma Ltd. | |||||||||||||
Full Title: A double blind, randomized, placebo-controlled, parallel group study of Sativex oromucosal spray (Sativex®; Nabiximols) as adjunctive therapy in relieving uncontrolled persistent chronic pain in pa... | |||||||||||||
Medical condition: Pain in patients with advanced cancer, who experience inadequate analgesia during optimized chronic opioid therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) GB (Completed) DE (Completed) PL (Completed) BG (Completed) HU (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001834-27 | Sponsor Protocol Number: GWEP1415 | Start Date*: 2015-01-14 | |||||||||||
Sponsor Name:GW Research Ltd | |||||||||||||
Full Title: An open label extension study to investigate the safety of cannabidiol (GWP42003-P; CBD) in children and adults with inadequately controlled Dravet or Lennox-Gastaut Syndromes | |||||||||||||
Medical condition: Dravet Syndrome (DS) or Lennox-Gastaut Syndrome (LGS) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) PL (Completed) NL (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001140-61 | Sponsor Protocol Number: GWDM1302 | Start Date*: 2013-12-30 | |||||||||||
Sponsor Name:GW Research Ltd. | |||||||||||||
Full Title: A randomised, double blind, placebo controlled, parallel group, dose ranging study of GWP42004 as add on to metformin in the treatment of participants with Type 2 diabetes. | |||||||||||||
Medical condition: Type 2 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000926-31 | Sponsor Protocol Number: GWMS1137 | Start Date*: 2011-06-29 | |||||||||||
Sponsor Name:GW Pharma Ltd. | |||||||||||||
Full Title: A Multicentre, Double-blind, Randomised Parallel Group, Placebo- controlled Study of the Effect of long-term treatment with Sativex on Cognitive Function and Mood of Patients with Spasticity due to... | |||||||||||||
Medical condition: Spasticity in multiple sclerosis (MS). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002939-34 | Sponsor Protocol Number: GWEP1424 | Start Date*: 2014-12-29 | |||||||||||
Sponsor Name:GW Research Ltd | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P) in children and young adults with Dravet syndrome. | |||||||||||||
Medical condition: Dravet syndrome | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) NL (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001133-18 | Sponsor Protocol Number: PH-2006-1 | Start Date*: 2006-05-25 | |||||||||||
Sponsor Name:Pharmos Corp. | |||||||||||||
Full Title: CANNABINOR DENTAL IMPACTION PAIN STUDY PROOF-OF-CONCEPT DOSE-RANGING STUDY | |||||||||||||
Medical condition: Cannabinor is as an analgesic and anti-inflammatory agent. By its nature, it has been designed to be more active at the CB2 peripheral receptors and have less activity at the central CB1 receptors.... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002940-42 | Sponsor Protocol Number: GWEP1414 | Start Date*: 2015-07-28 | |||||||||||
Sponsor Name:GW Research Ltd | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P; CBD) as adjunctive treatment for seizures associated with Lennox-Gastaut synd... | |||||||||||||
Medical condition: Lennox-Gastaut syndrome (LGS) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002941-23 | Sponsor Protocol Number: GWEP1423 | Start Date*: 2015-09-30 | |||||||||||
Sponsor Name:GW Research Ltd. | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P; CBD) as adjunctive treatment for seizures associated with Lennox- Gastaut syn... | |||||||||||||
Medical condition: Lennox-Gastaut syndrome | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002594-11 | Sponsor Protocol Number: GWEP1330 | Start Date*: 2015-01-24 | |||||||||||
Sponsor Name:GW Research Ltd. | |||||||||||||
Full Title: A double blind, randomized, placebo-controlled, two-part study to investigate the pharmacokinetics, followed by efficacy and safety of GWP42006 as add-on therapy in patients with inadequately contr... | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) ES (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022905-17 | Sponsor Protocol Number: GWCA1103 | Start Date*: 2011-12-26 | |||||||||||
Sponsor Name:GW Pharma Ltd. | |||||||||||||
Full Title: A two-part, placebo-controlled, study of the safety and efficacy of Sativex oromucosal spray (Sativex®; Nabiximols) as adjunctive therapy in relieving uncontrolled persistent chronic pain in patien... | |||||||||||||
Medical condition: Pain in patients with advanced cancer who have inadequate analgesia even with optimized chronic opioid therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) IT (Completed) GB (Completed) LT (Completed) PL (Completed) DE (Completed) HU (Completed) RO (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016529-32 | Sponsor Protocol Number: GWCA0999 | Start Date*: 2010-04-02 | |||||||||||
Sponsor Name:GW Pharma Ltd | |||||||||||||
Full Title: A multicenter, non-comparative, open-label extension study to assess the long term safety of Sativex oromucosal spray (Sativex®; Nabiximols) as adjunctive therapy in patients with uncontrolled pers... | |||||||||||||
Medical condition: Pain in patients with advanced cancer who experience inadequate analgesia during optimized chronic opioid therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) CZ (Completed) HU (Completed) DE (Completed) PL (Completed) LT (Completed) LV (Completed) EE (Prematurely Ended) BG (Completed) ES (Completed) IT (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
